Pasea, L. ., Mohamed, M. ., Dashtban, A. ., Bhuva, A. ., Mizani, M. A., Ali, S. ., … Banerjee, A. . (2025). Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study. Heart. http://doi.org/10.1136/heartjnl-2024-325046
T. Morris
First name
T.
Last name
Morris
Mizani, M. A., Dashtban, A. ., Pasea, L. ., Zeng, Q. ., Khunti, K. ., Valabhji, J. ., … Banerjee, A. . (2024). Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals. BMJ Open Diabetes Res Care, 12. http://doi.org/10.1136/bmjdrc-2024-004191
Dashtban, A. ., Mizani, M. A., Pasea, L. ., Denaxas, S. ., Corbett, R. ., Mamza, J. B., … Banerjee, A. . (2023). Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals. EBioMedicine, 89, 104489. http://doi.org/10.1016/j.ebiom.2023.104489
Mizani, M. A., Dashtban, A. ., Pasea, L. ., Lai, A. G., Thygesen, J. ., Tomlinson, C. ., … Banerjee, A. . (2022). Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort study. J R Soc Med, 1410768221131897. http://doi.org/10.1177/01410768221131897
Whittaker, H. ., Nordon, C. ., Rubino, A. ., Morris, T. ., Xu, Y. ., de Nigris, E. ., … Quint, J. K. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. http://doi.org/10.1136/thorax-2022-219039
Idris, I. ., Zhang, R. ., Mamza, J. B., Ford, M. ., Morris, T. ., Banerjee, A. ., & Khunti, K. . (2021). Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease. Diabetes Obes Metab, 23, 2207–2214. http://doi.org/10.1111/dom.14437
Idris, I. ., Zhang, R. ., Mamza, J. B., Ford, M. ., Morris, T. ., Banerjee, A. ., & Khunti, K. . (2022). Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting. Diabetes Obes Metab. http://doi.org/10.1111/dom.14799
Dashtban, A. ., Mizani, M. A., Denaxas, S. ., Nitsch, D. ., Quint, J. ., Corbett, R. ., … Banerjee, A. . (2022). A retrospective cohort study measured predicting and validating the impact of the COVID-19 pandemic in individuals with chronic kidney disease. Kidney Int. http://doi.org/10.1016/j.kint.2022.05.015
Whittaker, H. ., Rubino, A. ., Mullerova, H. ., Morris, T. ., Varghese, P. ., Xu, Y. ., … Quint, J. K. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis, 17, 427–437. http://doi.org/10.2147/copd.s346591
Martin-Merino, E. ., Johansson, S. ., Morris, T. ., & Rodriguez, L. A. G. (2011). Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Drug Saf. http://doi.org/10.2165/11594540-000000000-00000